Skip to main content
NORTHEAST PHARMACEUTICAL GROUP CO.,LTD logo

NORTHEAST PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 000597 ISIN · CNE0000009G0 LEI · 300300HX6JTMOEENF158 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,606 across all filing types
Latest filing 2026-01-06 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000597

About NORTHEAST PHARMACEUTICAL GROUP CO.,LTD

https://www.nepharm.com.cn

Northeast Pharmaceutical Group Co., Ltd. (NEPG) specializes in the research, development, manufacture, and distribution of active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates as a large-scale integrated pharmaceutical enterprise with a diverse product portfolio encompassing vitamins, antibiotics, cardiovascular agents, and digestive system medications. NEPG is recognized as a global leader in the production of Vitamin C and Vitamin B1, alongside significant output in caffeine and fosfomycin. Its manufacturing facilities adhere to international quality standards, including Good Manufacturing Practice (GMP) certifications. The company serves a broad international market, exporting products to numerous countries while maintaining a strong domestic presence. NEPG focuses on technological innovation and industrial scaling to provide high-quality chemical raw materials and pharmaceutical preparations for global healthcare needs.

Recent filings

Filing Released Lang Actions
关于非独立董事辞职暨选举职工代表董事的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the resignation of a non-independent director and the election of a new employee representative director to the company's board. It includes details about the director's term, qualifications, and compliance with relevant laws and regulations. There is no financial data, earnings information, or report publication mentioned. The content focuses on changes in the company's board of directors, which fits the category of Board/Management Information (MANG). The document length is short and it is not a report or a report announcement, so it is not classified as an Annual Report or similar. Therefore, the appropriate classification is MANG with high confidence.
2026-01-06 Chinese
关于股东回馈活动的自愿性信息披露公告
Regulatory Filings Classification · 95% confidence The document is a voluntary information disclosure announcement by the company about a shareholder reward activity. It details the timing, eligibility, and benefits of the shareholder reward event, including product discounts and participation instructions. There are no financial statements, regulatory filings, or report publications mentioned. The document is an announcement related to shareholder benefits and does not fit into categories like Annual Report, Earnings Release, or Proxy Solicitation. It is not a voting result or capital change notice. The content is about a shareholder reward program, which is a voluntary information disclosure. Therefore, the best fitting category is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit other specific categories.
2025-12-23 Chinese
股东会议事规则
Governance Information Classification · 100% confidence The document is titled as the "Shareholders Meeting Rules" of Northeast Pharmaceutical Group Co., Ltd. It details the procedures, powers, and regulations governing the company's shareholders meetings, including the convening, proposal submission, voting, and record-keeping processes. It does not contain financial statements, earnings data, or audit opinions. Instead, it is a governance document outlining internal rules and procedures related to shareholder meetings and corporate governance. Therefore, it fits best under the category of Governance Information (CGR). The document length is substantial and contains detailed governance rules, not just an announcement or summary, so it is not an RPA or RNS.
2025-12-15 Chinese
董事会议事规则
Governance Information Classification · 100% confidence The document is titled '东北制药集团股份有限公司 董事会议事规则' which translates to 'Northeast Pharmaceutical Group Co., Ltd. Board Meeting Rules'. The content details the rules and procedures for the board of directors' meetings, including their powers, meeting notification procedures, voting, and special provisions for independent directors. It is a governance document outlining internal rules and board structure rather than a report of financial results, announcements, or regulatory filings. There is no indication of financial data, audit information, or meeting minutes results. This fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-12-15 Chinese
关于回购注销部分限制性股票减少注册资本暨通知债权人的公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from Northeast Pharmaceutical Group Co., Ltd. regarding the repurchase and cancellation of part of its restricted shares, which will reduce the registered capital. It includes details about the board and shareholder meetings approving the repurchase, the number of shares to be canceled, and a notification to creditors about their rights to claim debts or request guarantees within 45 days. The document is a formal public notice related to a capital reduction due to share repurchase and cancellation, not a financial report or detailed financial data. It is not an annual or interim report, earnings release, or audit report. It is also not a regulatory certification or a voting result announcement. The content fits the definition of a Share Issue/Capital Change announcement, as it concerns changes in the company's capital structure due to share repurchase and cancellation.
2025-12-15 Chinese
独立董事工作细则
Governance Information Classification · 95% confidence The document is titled '东北制药集团股份有限公司 独立董事工作细则' which translates to 'Northeast Pharmaceutical Group Co., Ltd. Independent Director Work Rules'. It is a detailed governance document outlining the roles, responsibilities, qualifications, appointment, and working conditions of independent directors within the company. It references relevant laws, regulations, and stock exchange rules, and includes provisions on governance structure and director duties. There is no financial data, earnings information, or report publication announcement. The content is focused on governance practices and internal rules related to the board and independent directors. Therefore, the document fits best under the category of Governance Information (CGR). The document length (6146 characters) and detailed content support this classification with high confidence.
2025-12-15 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.